Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

The Immune Checkpoint Kick Start: Optimization of Neoadjuvant Combination Therapy Using Game Theory.

West J, Robertson-Tessi M, Luddy K, Park DS, Williamson DFK, Harmon C, Khong HT, Brown J, Anderson ARA.

JCO Clin Cancer Inform. 2019 Feb;(3):1-12. doi: 10.1200/CCI.18.00078.

2.

Corrigendum to ``A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy'' [Journal of Theoretical Biology 380 (2015) 569-584].

Robertson-Tessi M, El-Kareh A, Goriely A.

J Theor Biol. 2019 Mar 7;464:181. doi: 10.1016/j.jtbi.2018.12.040. Epub 2019 Jan 11. No abstract available.

PMID:
30610835
3.

Corrigendum to ``A mathematical model of tumor-immune interactions'' [Journal of Theoretical Biology 294 (2012) 56-73].

Robertson-Tessi M, El-Kareh A, Goriely A.

J Theor Biol. 2019 Mar 7;464:180. doi: 10.1016/j.jtbi.2018.12.041. Epub 2019 Jan 11. No abstract available.

PMID:
30610834
4.

Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer Immunotherapy.

Yagawa Y, Robertson-Tessi M, Zhou SL, Anderson ARA, Mulé JJ, Mailloux AW.

Sci Rep. 2017 Nov 22;7(1):15996. doi: 10.1038/s41598-017-15924-2.

5.

Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution.

Ibrahim-Hashim A, Robertson-Tessi M, Enriquez-Navas PM, Damaghi M, Balagurunathan Y, Wojtkowiak JW, Russell S, Yoonseok K, Lloyd MC, Bui MM, Brown JS, Anderson ARA, Gillies RJ, Gatenby RA.

Cancer Res. 2017 May 1;77(9):2242-2254. doi: 10.1158/0008-5472.CAN-16-2844. Epub 2017 Mar 1.

6.

Stochasticity in the Genotype-Phenotype Map: Implications for the Robustness and Persistence of Bet-Hedging.

Nichol D, Robertson-Tessi M, Jeavons P, Anderson AR.

Genetics. 2016 Dec;204(4):1523-1539. Epub 2016 Oct 21.

7.

Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions.

Poleszczuk JT, Luddy KA, Prokopiou S, Robertson-Tessi M, Moros EG, Fishman M, Djeu JY, Finkelstein SE, Enderling H.

Cancer Res. 2016 Mar 1;76(5):1009-18. doi: 10.1158/0008-5472.CAN-15-1423. Epub 2016 Feb 1.

8.

A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy.

Robertson-Tessi M, El-Kareh A, Goriely A.

J Theor Biol. 2015 Sep 7;380:569-84. doi: 10.1016/j.jtbi.2015.06.009. Epub 2015 Jun 16. Erratum in: J Theor Biol. 2019 Mar 7;464:181.

PMID:
26087282
9.

Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes.

Robertson-Tessi M, Gillies RJ, Gatenby RA, Anderson AR.

Cancer Res. 2015 Apr 15;75(8):1567-79. doi: 10.1158/0008-5472.CAN-14-1428.

10.

Big Bang and context-driven collapse.

Robertson-Tessi M, Anderson AR.

Nat Genet. 2015 Mar;47(3):196-7. doi: 10.1038/ng.3231.

PMID:
25711865
11.

The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition.

Luddy KA, Robertson-Tessi M, Tafreshi NK, Soliman H, Morse DL.

Front Immunol. 2014 Oct 20;5:429. doi: 10.3389/fimmu.2014.00429. eCollection 2014. Review.

12.

A mathematical model of tumor-immune interactions.

Robertson-Tessi M, El-Kareh A, Goriely A.

J Theor Biol. 2012 Feb 7;294:56-73. doi: 10.1016/j.jtbi.2011.10.027. Epub 2011 Oct 28. Erratum in: J Theor Biol. 2019 Mar 7;464:180.

PMID:
22051568

Supplemental Content

Loading ...
Support Center